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ing needs and priorities changed from admission to discharge. 
Ten SCT patients completed both pre- and post-evaluation sur- 
veys. Results of this study highlight he need for greater attention 
to the psychosocial needs of transplant patients during the pre- 
and post-transplant period. Patients rated psychosocial issues very 
high on importance, but rated the teaching they received to help 
them deal with these concerns as relatively low. More attention 
should be devoted to the psychosocial needs and concerns of 
transplant patients throughout the entire SCT process. Learning 
about complimentary therapies that may be helpful in symptom 
management was not considered important to SCT patients, nor 
did they feel the teaching they r ceived helped them to under- 
stand complimentary therapies. Further study regarding the role 
of complimentary therapy in SCT and how patients are educated 
about these therapies i needed. Patients value knowing as much 
as possible about SCT, but commented that the large quantity of 
complex information limited their ability to retain the information 
they were given about transplantation. Both the timing and 
"dosage" of patient education about SCT requires additional 
study. Educating patients about SCT may be best accomplished in 
small doses with content hat varies across different phases 
throughout the transplant process. 
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Stem ceil transplantation is widely used method for the treat- 
ment of hematological malignancy and offers potential long- 
term survival. But cancer patient has defective sperm and low 
sperm counts a a consequence of the disease and its treatment. 
Irradiation and chemotherapy each compromise fertility by 
exerting cytotoxic effects on gametogenesis. The degree of 
gonadaI effect is governed by the therapeutic regimen(i.e., type, 
dose, schedule) and duration of treatment. This study was eval- 
uated the sperm quality before stem cell transplantation. 
Records of 50 patients with hematological malignance, who 
banked their sperm between Aug. 1998 and Aug. 2001, were 
reviewed. The acute leukemia group had undergone 
chemotherapy or radiation therapy before sperm banking. CML 
group had undergone conservative treatment. Some patients of 
SAA group had got ALG treatment. The sperm quality was 
examined by Volume, MSC(motile sperm count) and Motility. 
60% of all the patients were ol igospermic((20xl06/mL). 
Oligospermia occurred in 72% of the patients in Acute 
leukemia(n=13), 82% in the CML(n=14), and 20% in 
SAA(n=3). Total sperm volume did not differ significantly 
between the three groups. Compared with the other two 
leukemia group, patients in SAA group had higher 
MSC(p=0.0002) and Motility(p=0.0181). Sperm quality of SAA 
did not differ significantly between ALG treatment group and 
no treatment group. In conclusion, sperm quality of the 
leukemia patient who had got chemotherapy or radiation treat- 
ment was poor. The currently preferred practice for patients 
with cancer is to collect sperm before initiation of chemothera- 
py; therefore careful consideration of each individual's case 
must be the rule when determining how long therapy can be 
delayed without jeopardizing the patient's health. As cancer 
therapy may further impair sperm quality, patients hould be 
offered the chance to bank sperm before undergoing cancer 
therapy. 
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DEVELOPING A DATA SYSTEM TO MONITOR INFECTIOUS COMPLICA- 
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Susceptibility to infections continues to be a major source of 
morbidity and mortality during the course of hematopoetic cell 
transplantation (HCT). Advances in infection control including 
the use of growth factors, new antibiotics and strategies to prevent 
infections have improved survival rates and outcomes. However, 
resistant bacteria, latent viruses and fungal pathogens continue to 
challenge the success of HCT. As transplant programs investigate 
novel approaches to transplant including the use of reduced inten- 
sity transplants, utilizing alternative donor sources, and experi- 
menting with new agents to prevent or treat GVHD, the pattern 
and timing of pathogens may be altered. Transplant centers moni- 
tor and report infectious complications  a routine basis and 
institute measures to reduce the incidence of serious infections. 
Duke University Medical Center Adult HCT Program has devel- 
oped an integrated ata management system that allows the clini- 
cal staff to review infectious complications in relationship to a 
number of parameters. As the faculty continue to develop novel 
approaches to transplant, reat older patients, manipulate grafts, 
utilize new conditioning regimens and treat different underlying 
diseases, the emergence of opportunistic infections can be not 
only monitored but can also be linked to a number of variables. 
To ensure a comprehensive, authoritative base of information for 
ongoing analysis and review, Duke HCT has arranged for auto- 
mated data feeds from other programs uch as Microbiology, 
Infection Control, and Pulmonary Medicine. Further automation 
merges data from these external sources with Duke HCT own 
internal database. The results are then used to populate a number 
of analysis templates for quarterly review. Correlations and trends 
can be established for any or all of the variables listed above, and 
can be examined from both high level: program as whole, alloge- 
nieic, non-ablative cord blood or autologous transplants, and from 
lower level: by disease, protocol, gender, age, conditioning regi- 
men, and GVHD prophylaxis. Because the data gathering and 
presentation require little manual intervention, the results are 
readily available to clinical and administrative staff. With these 
data in hand, staff can more easily discern statistically significant 
trends and take remedial action quickly and efficiently. 
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The Bone Marrow Transplant (BMT) program at The Chil- 
dren's Hospital (TCH) in Denver, Colorado serves patients 
from the Rocky Mountain Area that includes nine states plus 
patients referred from other countries. The patients ages range 
from birth to the late twenties. The transplants are autologous 
and allogenic including matched related, unrelated, and cord 
blood. BMT patients are on between 6 and 20 medications as 
part of their supportive care in the post transplant time period. 
Nurses play a valuable role in educating patients and families of 
the importance and interactions of their medications, evaluat- 
ing compliance issues, and problem-solving roadblocks to suc- 
cessful medication administration. Home medication teaching 
is a multidiseiplinary process involving nurses, pharmacy and 
physicians. The process begins in-patient weeks prior to dis- 
charge and continues at each outpatient clinic visit. We will 
show several tools that help patients with safe medication 
administration. These are available in English and Spanish. 
Tools include: patient/parent medication list including side 
effects, clinic medication tracking list, patient/parent instruc- 
tion form (given with any medication change during the clinic 
visit), patient/parent medication checklist for home use, and 
medication calendars. In spite of this thorough medication 
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